First, seasonal influenza activity remains low nationally, with a low percentage of specimens testing positive for influenza in clinical laboratories.

Outpatient respiratory illness visits remain above the national baseline, with 2.6% of patient visits attributed to respiratory illness.

Long-term care facilities continue to report a low percentage of influenza-positive tests among residents.

FluSurv-NET data show a total of 17,526 laboratory-confirmed influenza-associated hospitalizations, with the highest rates among adults aged 65 and older.

The majority of deaths attributed to pneumonia, influenza, or COVID-19 occurred in week 8, above the epidemic threshold.

Two influenza-associated pediatric deaths were reported during the 2022-2023 season.

Virus characterization indicates that most circulating influenza viruses are similar to the reference viruses used in the vaccine.

Influenza viruses continue to show susceptibility to antiviral medications.

CDC emphasizes the importance of annual flu vaccination and recommends the use of antiviral drugs for treatment.

Overall, the surveillance data provide valuable information for predicting future ILI occurrence and guiding public health measures.